# Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Source: https://onco.cc/trials/nct07217704/  
OnCo record `nct07217704` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of [18F]FAPI-74 PET/CT in oesophageal cancer and gastric & gastro-oesophageal junction cancer, run by SOFIE, now recruiting.

## Summary

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. is a phase 3 interventional study registered as NCT07217704 by SOFIE, with 200 participants planned, started 2025-11-14 and due to reach its primary completion in 2027-08-30. Interventions recorded: [18F]FAPI-74 PET/CT.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07217704
- Phase: 3
- Setting: A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [¹⁸F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults With Gastric or Esophageal Cancer
- Sponsor: SOFIE
- Enrolled: 200

## Sources

- ClinicalTrials.gov NCT07217704: https://clinicaltrials.gov/study/NCT07217704

## Connected records

- cancers: [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Oesophageal cancer](https://onco.cc/cancers/esophageal/)
- companies: [SOFIE Biosciences](https://onco.cc/companies/sofie-biosciences/)

---
JSON: https://onco.cc/api/v1/entities/nct07217704.json